Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

XXII Stock Annual Income Statement. Download in Excel

22nd Century Group Inc. logo

22nd Century Group Inc.

Sector: Healthcare   

Industry: Biotechnology

4.95
 
USD
  
0.22
  
(4.65%)
Previous close: 4.73  Open: 4.74  Bid: 4.95  Ask: 5.25
52 week range    
3.90   
   581.85
Mkt Cap: 2 M  Avg Vol (90 Days): 71,041
Peers   
MO / 
PM / 
BTI / 
Last updated: Monday 23rd December 2024

Stock Rankings

46
MarketXLS Rank
80
Value
23
Technical
36
Quality
How are these ranks calculated?
Search for a stock

Financials

XXII Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends10 M
AcquisitionExpense1 M223000.0
Amortization of intangibles-265284.0-454612.0-516056.0-593562.0-819640.08 M8 M8 M7 M
Basic EPS from continuing operations-3.15-33.6-50.4-74.4-158.72
Basic EPS total-3.15-33.6-50.4-74.4-116.48
Basic weighted shares outstanding4 M5 M5 M7 M8 M8 M578387.0650866.0803487.01 M
BasicDiscontinuousOperations-66.56
Cost of sales-252002.0-9 M-13 M-17 M-26 M26 M27 M29 M39 M41 M
Depreciation230012.0319699.0326124.0353435.0522695.0589000.0688000.01 M673000.0852000.0
Depreciation unreconciled462772.0774311.0842180.0946997.01 M1 M1 M1 M
DepreciationAndAmortization462772.0774311.0842180.0946997.01 M1 M1 M1 M673000.0852000.0
Diluted EPS total-3.9-2.4-2.25-1.95-0.9-3.15-33.6-50.4-74.4-116.48
Diluted normalized net income/share-50.4-74.4-158.72
Diluted weighted shares outstanding4 M5 M5 M7 M9 M8 M650866.0803487.01 M
DilutedDiscontinuousOperations-66.56
Earnings from equity interest-101165.0-95684.0-202338.0346180.0
EarningsFromEquityInterestNetOfTax-101165.0-95684.0-202338.0346180.0
ExciseTaxes-6 M-7 M-9 M10 M10 M13 M10 M
GainOnSaleOfPPE71121.0-15130.087351.0362000.0111000.0
GainOnSaleOfSecurity30383.031198.016885.0457660.01 M-1 M1 M-7 M313000.0219000.0
GainsLossOnDisposalOfDiscontinuedOperations455000.0-455000.0
GeneralAndAdministrativeExpense9 M8 M6 M7 M8 M13 M15 M26 M32 M31 M
Gross operating profit30555.0-580562.0-429699.0-707912.0898987.015000.01 M1 M2 M-9 M
ImpairmentOfCapitalAssets1 M552000.0
Income before tax-16 M-11 M-12 M-13 M-8 M-27 M-20 M-33 M-37 M-55 M
Income restructuring and M&A-624320.0-29104.0-10939.0880838.032 M692000.02 M
Income taxes-160319.0-4 M-2 M-1 M-1 M-6 M38000.014000.021000.047000.0
Interest income-4 M144550.029615.0-157809.015 M
InterestExpenseNonOperating7094.052982.037745.029104.010939.056000.072000.058000.055000.09 M
MiscOtherSpecialCharges87000.01000.03 M-3 M-561000.0
Net income from total operations-16 M-11 M-12 M-13 M-8 M-27 M-20 M-33 M-60 M-141 M
NetIncomeCommonStockholders-16 M-11 M-12 M-13 M-8 M-27 M-20 M-33 M-60 M-151 M
NetIncomeContinuousOperations-16 M-11 M-12 M-13 M-8 M-27 M-20 M-33 M-60 M-55 M
NetIncomeDiscontinuousOperations-46 M-172 M
NetNonOperatingInterestIncomeExpense-4 M91568.0-8130.0-186913.015 M-56000.0-72000.0-58000.0-55000.09 M
NonRecurringOperationExpense-1000000.02 M-5 M
Normalized income-40 M
Operating income-12 M-12 M-11 M-13 M-24 M-24 M-19 M-28 M-34 M-45 M
Operating income before depreciation (EBITDA)-15 M-10 M-11 M-12 M-7 M-25 M-18 M-31 M-33 M-40 M
OperatingExpense-12 M-11 M-11 M-13 M-25 M24 M21 M30 M35 M34 M
Other income net-339.079616.0185453.0-457660.0-1 M2 M594000.04 M3 M-2 M
OtherGainLossFromDispositionOfDiscontinuedOperations-47 M-172 M
OtherGandA9 M8 M6 M7 M8 M13 M15 M26 M32 M31 M
OtherImpairmentOfCapitalAssets1 M2 M78000.035000.01 M
OtherOperatingExpenses1 M250000.0335000.078000.0-327000.03 M
OtherunderPreferredStockDividend10 M
PreferredStockDividends10 M
PromotionAndAdvertising-30000.0-229000.0-325000.0-75000.0-36000.0
RentAndLandingFees9 M8 M6 M7 M8 M
Research & development expense1 M2 M2 M3 M15 M8 M4 M4 M4 M3 M
ResearchExpense1 M2 M2 M3 M15 M8 M4 M4 M4 M3 M
RestructringAndMnAIncome-624320.0-29104.0-10939.0880838.032 M692000.02 M
Revenue per share232760.0454612.0516056.0593562.0819640.0836000.0658000.08 M7 M-2 M
SalariesAndWages-2 M-2 M-880509.0-941650.0-3 M4 M2 M4 M5 M3 M
Selling Gen & administrative expense9 M9 M8 M8 M9 M13 M15 M26 M32 M31 M
SellingAndMarketingExpense85930.01 M2 M1 M9 M
SellingExpense85930.01 M2 M1 M9 M
Special income/charges624320.01000000.029104.010939.0-2 M-32 M-692000.0-3 M
Total Income available for interest expense (EBIT)-16 M-11 M-12 M-13 M-8 M-27 M-20 M-33 M-36 M-45 M
Total common shares outstanding4 M5 M6 M8 M8 M9 M623395.0678909.0898766.056 M
Total net income-16 M-11 M-12 M-13 M-8 M-27 M-20 M-33 M-60 M-141 M
Total ordinary shares46 M46 M46 M46 M46 M46 M46 M46 M46 M46 M
Total revenues528991.09 M12 M17 M27 M26 M28 M31 M41 M32 M
TotalExpenses-12 M-21 M-24 M-30 M-50 M49 M47 M59 M74 M75 M
TotalRevenue528991.09 M12 M17 M26 M26 M28 M31 M41 M32 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University